These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 36610378)

  • 1. Targeted and explorative profiling of kallikrein proteases and global proteome biology of pancreatic ductal adenocarcinoma, chronic pancreatitis, and normal pancreas highlights disease-specific proteome remodelling.
    Werner J; Bernhard P; Cosenza-Contreras M; Pinter N; Fahrner M; Pallavi P; Eberhard J; Bronsert P; Rückert F; Schilling O
    Neoplasia; 2023 Feb; 36():100871. PubMed ID: 36610378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA Signatures for Pancreatic Cancer and Chronic Pancreatitis: Expression Profiling by NGS.
    Singh N; Khan IA; Rashid S; Rashid S; Roy S; Kaushik K; Kumar A; Das P; Lalwani S; Gupta D; Gunjan D; Dash NR; Chauhan SS; Gupta S; Saraya A
    Pancreas; 2024 Mar; 53(3):e260-e267. PubMed ID: 38345909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Panel of serum miRNAs as potential non-invasive biomarkers for pancreatic ductal adenocarcinoma.
    Khan IA; Rashid S; Singh N; Rashid S; Singh V; Gunjan D; Das P; Dash NR; Pandey RM; Chauhan SS; Gupta S; Saraya A
    Sci Rep; 2021 Feb; 11(1):2824. PubMed ID: 33531550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of pancreatic ductal adenocarcinoma from chronic pancreatitis by PAM4 immunohistochemistry.
    Shi C; Merchant N; Newsome G; Goldenberg DM; Gold DV
    Arch Pathol Lab Med; 2014 Feb; 138(2):220-8. PubMed ID: 24476519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma.
    Munding JB; Adai AT; Maghnouj A; Urbanik A; Zöllner H; Liffers ST; Chromik AM; Uhl W; Szafranska-Schwarzbach AE; Tannapfel A; Hahn SA
    Int J Cancer; 2012 Jul; 131(2):E86-95. PubMed ID: 21953293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood small extracellular vesicles derived miRNAs to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.
    Guo S; Qin H; Liu K; Wang H; Bai S; Liu S; Shao Z; Zhang Y; Song B; Xu X; Shen J; Zeng P; Shi X; Chen H; Gao S; Xu J; Pan Y; Xiong L; Li F; Zhang D; Jiao X; Jin G
    Clin Transl Med; 2021 Sep; 11(9):e520. PubMed ID: 34586739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of immunohistochemical IMP3 expression in core needle biopsies of pancreatic ductal adenocarcinoma.
    Wachter DL; Schlabrakowski A; Hoegel J; Kristiansen G; Hartmann A; Riener MO
    Am J Surg Pathol; 2011 Jun; 35(6):873-7. PubMed ID: 21566520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatiotemporal proteomic analyses during pancreas cancer progression identifies serine/threonine stress kinase 4 (STK4) as a novel candidate biomarker for early stage disease.
    Mirus JE; Zhang Y; Hollingsworth MA; Solan JL; Lampe PD; Hingorani SR
    Mol Cell Proteomics; 2014 Dec; 13(12):3484-96. PubMed ID: 25225358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant upregulation of KLK10 promotes metastasis via enhancement of EMT and FAK/SRC/ERK axis in PDAC.
    Cao XY; Zhang XX; Yang MW; Hu LP; Jiang SH; Tian GA; Zhu LL; Li Q; Sun YW; Zhang ZG
    Biochem Biophys Res Commun; 2018 May; 499(3):584-593. PubMed ID: 29621546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation.
    Campa D; Pastore M; Capurso G; Hackert T; Di Leo M; Izbicki JR; Khaw KT; Gioffreda D; Kupcinskas J; Pasquali C; Macinga P; Kaaks R; Stigliano S; Peeters PH; Key TJ; Talar-Wojnarowska R; Vodicka P; Valente R; Vashist YK; Salvia R; Papaconstantinou I; Shimizu Y; Valsuani C; Zambon CF; Gazouli M; Valantiene I; Niesen W; Mohelnikova-Duchonova B; Hara K; Soucek P; Malecka-Panas E; Bueno-de-Mesquita HBA; Johnson T; Brenner H; Tavano F; Fogar P; Ito H; Sperti C; Butterbach K; Latiano A; Andriulli A; Cavestro GM; Busch ORC; Dijk F; Greenhalf W; Matsuo K; Lombardo C; Strobel O; König AK; Cuk K; Strothmann H; Katzke V; Cantore M; Mambrini A; Oliverius M; Pezzilli R; Landi S; Canzian F
    Int J Cancer; 2018 Jan; 142(2):290-296. PubMed ID: 28913878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial Peptide Human Neutrophil Peptide 1 as a Potential Link Between Chronic Inflammation and Ductal Adenocarcinoma of the Pancreas.
    Pausch T; Adolph S; Felix K; Bauer AS; Bergmann F; Werner J; Hartwig W
    Pancreas; 2018; 47(5):561-567. PubMed ID: 29683978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A microRNA signature in circulating exosomes is superior to exosomal glypican-1 levels for diagnosing pancreatic cancer.
    Lai X; Wang M; McElyea SD; Sherman S; House M; Korc M
    Cancer Lett; 2017 May; 393():86-93. PubMed ID: 28232049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic Juice Exosomal MicroRNAs as Biomarkers for Detection of Pancreatic Ductal Adenocarcinoma.
    Nakamura S; Sadakari Y; Ohtsuka T; Okayama T; Nakashima Y; Gotoh Y; Saeki K; Mori Y; Nakata K; Miyasaka Y; Onishi H; Oda Y; Goggins M; Nakamura M
    Ann Surg Oncol; 2019 Jul; 26(7):2104-2111. PubMed ID: 30820789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic ductal adenocarcinoma cells employ integrin α6β4 to form hemidesmosomes and regulate cell proliferation.
    Humphries JD; Zha J; Burns J; Askari JA; Below CR; Chastney MR; Jones MC; Mironov A; Knight D; O'Reilly DA; Dunne MJ; Garrod DR; Jorgensen C; Humphries MJ
    Matrix Biol; 2022 Jun; 110():16-39. PubMed ID: 35405272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic analyses of ECM during pancreatic ductal adenocarcinoma progression reveal different contributions by tumor and stromal cells.
    Tian C; Clauser KR; Öhlund D; Rickelt S; Huang Y; Gupta M; Mani DR; Carr SA; Tuveson DA; Hynes RO
    Proc Natl Acad Sci U S A; 2019 Sep; 116(39):19609-19618. PubMed ID: 31484774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of MSX2 mRNA in brush cytology specimens distinguished pancreatic carcinoma from chronic pancreatitis.
    Satoh K; Hamada S; Kanno A; Ishida K; Ito H; Hirota M; Masamune A; Egawa S; Unno M; Shimosegawa T
    Cancer Sci; 2011 Jan; 102(1):157-61. PubMed ID: 20961362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct pathophysiological cytokine profiles for discrimination between autoimmune pancreatitis, chronic pancreatitis, and pancreatic ductal adenocarcinoma.
    Ghassem-Zadeh S; Gaida MM; Szanyi S; Acha-Orbea H; Frossard JL; Hinz U; Hackert T; Strobel O; Felix K
    J Transl Med; 2017 Jun; 15(1):126. PubMed ID: 28578701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignancy in chronic pancreatitis: analysis of diagnostic procedures and proposal of a clinical algorithm.
    Rückert F; Brussig T; Kuhn M; Kersting S; Bunk A; Hunger M; Saeger HD; Niedergethmann M; Post S; Grützmann R
    Pancreatology; 2013; 13(3):243-9. PubMed ID: 23719595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-level integrative analysis of the roles of lncRNAs and differential mRNAs in the progression of chronic pancreatitis to pancreatic ductal adenocarcinoma.
    Zhao Z; Luo Q; Liu Y; Jiang K; Zhou L; Dai R; Wang H
    BMC Genomics; 2023 Mar; 24(1):101. PubMed ID: 36879212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant chemo- or chemo-radiation-therapy of pancreatic ductal adenocarcinoma differentially shift ECM composition, complement activation, energy metabolism and ribosomal proteins of the residual tumor mass.
    Stillger MN; Kurowski K; Bronsert P; Brombacher E; Kreutz C; Werner M; Tang L; Timme-Bronsert S; Schilling O
    Int J Cancer; 2024 Jun; 154(12):2162-2175. PubMed ID: 38353498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.